Non-Proliferative MDS
Showing 26 - 50 of >10,000
Non Proliferative Diabetic Retinopathy Trial in Guangzhou (Prompt panretinal photocoagulation, 25G Pars-plana vitrectomy)
Recruiting
- Non Proliferative Diabetic Retinopathy
- Prompt panretinal photocoagulation
- 25G Pars-plana vitrectomy
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Apr 20, 2021
Non-proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy, Diabetic Macular Edema Trial in Riyadh (Bevacizumab)
Completed
- Non-proliferative Diabetic Retinopathy
- +2 more
-
Riyadh, Saudi ArabiaKing Khaled Eye Specialist Hospital
Dec 2, 2021
Retinopathy, Diabetic Trial in Rochester (Aflibercept Injection, Sham injection)
Withdrawn
- Retinopathy, Diabetic
- Aflibercept Injection
- Sham injection
-
Rochester, New YorkFlaum Eye Institute, University of Rochester Medical Center
Apr 29, 2021
AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)
Recruiting
- AML
- +8 more
- Clofarabine
- +5 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 13, 2022
Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS) Trial in Worldwide (S64315 once a week, S64315 twice a week)
Completed
- Acute Myeloid Leukaemia (AML)
- Myelodysplastic Syndrome (MDS)
- S64315 once a week
- S64315 twice a week
-
New Haven, Connecticut
- +8 more
May 17, 2022
Severe Aplastic Anemia, MDS (Myelodysplastic Syndrome) Trial in Baltimore, Bethesda, Minneapolis (Miltenyi CD34 Reagent System,
Recruiting
- Severe Aplastic Anemia
- MDS (Myelodysplastic Syndrome)
- Miltenyi CD34 Reagent System
- Donor derived G-CSF mobilized PBC
-
Baltimore, Maryland
- +2 more
Jan 25, 2023
Diabetic Retinopathy Trial in Worldwide (Runcaciguat (BAY1101042), Placebo)
Recruiting
- Diabetic Retinopathy
- Runcaciguat (BAY1101042)
- Placebo
-
Redlands, California
- +85 more
Jan 30, 2023
Retinal Neurodegeneration In Type 2 Diabetes Mellitus Detected
Not yet recruiting
- Retinal Neuropathy
- Neurodegeneration
- Optical Coherence Tomography (OCT)
- (no location specified)
Mar 19, 2021
MDS Trial in Worldwide (Luspatercept, Epoetin Alfa)
Not yet recruiting
- Myelodysplastic Syndromes
- Luspatercept
- Epoetin Alfa
-
Concord, California
- +100 more
Jul 20, 2023
AML - Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome), Mixed Phenotype Acute Leukemia Trial in Palo Alto (T-allo10)
Recruiting
- AML - Acute Myeloid Leukemia
- +5 more
- T-allo10
-
Palo Alto, CaliforniaLucile Packard Children's Hospital
Feb 2, 2022
GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)
Recruiting
- GVHD
- +15 more
- FLUDARABINE
- +6 more
-
Boston, MassachusettsMassachusetts General Hospital
Sep 30, 2021
Diabetic Retinopathy Trial in Dijon (monospot panretinal photocoagulation, multispot panretinal photocoagulation)
Recruiting
- Diabetic Retinopathy
- monospot panretinal photocoagulation
- multispot panretinal photocoagulation
-
Dijon, FranceCHU dijon Bourgogne
Jun 8, 2021
Diabetic Macular Edema, Non-proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy Trial in Torrance
Completed
- Diabetic Macular Edema
- +2 more
- dexamethasone intravitreal implant
- intravitreal bevacizumab
-
Torrance, CaliforniaRetina Macula Institute
Mar 8, 2021
Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML) Trial in United States
Recruiting
- Acute Myelogenous Leukemia (AML)
- +5 more
- Conditioning Chemotherapy
- Cord blood graft
-
Basking Ridge, New Jersey
- +6 more
May 22, 2023
Using a Topical Fluorescence Reagent and Optical Imaging
Completed
- Skin Lesions
-
Kiryat Bialik, Israel
- +1 more
Nov 17, 2020
Samples of Bone Marrow Aspiration From Myelodysplastic Syndrome
Recruiting
- Myelodysplastic Syndromes
- Blood test
-
Jerusalem, IsraelShaare Zedek Medical Center
Nov 27, 2023
AML, MDS Trial in Belgium, United States (NKR-2)
Completed
- AML
- MDS
- NKR-2
-
Aurora, Colorado
- +6 more
Apr 30, 2021
Patients With Vascular Parkinsonism and Parkinson's Disease
Recruiting
- Vascular Parkinsonism
- Parkinson's Disease
- Neuro-radiological tools:
- +11 more
-
Cairo, EgyptAin Shams University
Dec 5, 2021
Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome Trial in Duarte (Fludarabine, Itacitinib Adipate,
Active, not recruiting
- Acute Leukemia
- +4 more
- Fludarabine
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Azacitidine in International Prognostic Scoring System
Recruiting
- Myelodysplastic Syndromes
- +2 more
-
Hefei, Anhui, China
- +16 more
Sep 6, 2022
MDS, Anemia Trial in Germany (Luspatercept Injection)
Recruiting
- Myelodysplastic Syndromes
- Anemia
- Luspatercept Injection
-
Berlin, Germany
- +18 more
Jan 25, 2023
Endometrial Tissues and Mononuclear Cells Receptivity in
Completed
- Endometrial Hyperplasia Without Atypia
- +6 more
- endometrial tissue and peripheral blood mononuclear cells receptivity
- (no location specified)
Oct 29, 2023
MDS, Ferroptosis Trial in Pessac (Biological sampling)
Not yet recruiting
- Myelodysplastic Syndromes
- Ferroptosis
- Biological sampling
-
Pessac, France
- +2 more
Jun 19, 2023
MDS Trial in Seoul (cyclophosphamide, fludarabine, and antithymocyte globulin)
Active, not recruiting
- Myelodysplastic Syndromes
- cyclophosphamide, fludarabine, and antithymocyte globulin
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023